Literature DB >> 7137986

Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading.

W M Bennett, W C Elliott, D C Houghton, D N Gilbert, J DeFehr, D A McCarron.   

Abstract

Since gentamicin accumulates in the renal cortex before renal failure and calcium reduces gentamicin binding to cell membranes, we examined the effect of dietary calcium loading on gentamicin toxicity in male F344 rats. Rats were fed either a normal (0.5%)- or a high (4%)-calcium-content chow. Calcium loading did not alter inulin clearance, urinary excretion of sodium or total osmoles, or serum ionized calcium. However, calcium loading caused elevation of urinary calcium excretion and lowered urinary cyclic AMP levels. The data suggest that calcium loading may have slowed the accumulation of gentamicin (40 mg/kg per day) by the renal cortex. Histological and functional evidence of nephrotoxicity was delayed in onset and attenuated in magnitude. The results indicate that dietary calcium loading reduces experimental gentamicin nephrotoxicity. Protection may be associated with slower renal cortical accumulation of gentamicin. Calcium-dependent membrane or intracellular events may mediate this effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137986      PMCID: PMC183773          DOI: 10.1128/AAC.22.3.508

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Calcium metabolism at the cellular level.

Authors:  A B Borle
Journal:  Fed Proc       Date:  1973-09

2.  Mode of action of parathyroid hormone and cyclic adenosine 3',5'-monophosphate on renal tubular phosphate reabsorption in the dog.

Authors:  Z S Agus; J B Puschett; D Senesky; M Goldberg
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

3.  Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration.

Authors:  D N Gilbert; D C Houghton; W M Bennett; C E Plamp; K Reger; G A Porter
Journal:  Proc Soc Exp Biol Med       Date:  1979-01

4.  Distribution of 14C-gentamicin in vascular smooth muscle.

Authors:  F R Goodman
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

5.  A light and electron microscopic analysis of gentamicin nephrotoxicity in rats.

Authors:  D C Houghton; M Hartnett; M Campbell-Boswell; G Porter; W Bennett
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

6.  Effect of sodium intake on gentamicin nephrotoxicity in the rat.

Authors:  W M Bennett; M N Hartnett; D Gilbert; D Houghton; G A Porter
Journal:  Proc Soc Exp Biol Med       Date:  1976-04

7.  Gentamicin binding to serum and plasma proteins.

Authors:  D R Myers; J DeFehr; W M Bennet; G A Porter; G D Olsen
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

8.  Influence of parathyroid hormone on glomerular ultrafiltration in the rat.

Authors:  I Ichikawa; H D Humes; T P Dousa; B M Brenner
Journal:  Am J Physiol       Date:  1978-05

9.  Gentamicin blockade of slow Ca++ channels in atrial myocardium of guinea pigs.

Authors:  H R Adams; L R Durrett
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

10.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

View more
  10 in total

1.  Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack.

Authors:  R A Zager
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  Interaction of gentamicin with phosphatidylserine/phosphatidylcholine mixtures in adsorption monolayers and thin liquid films: morphology and thermodynamic properties.

Authors:  Georgi D Georgiev; Georgi As Georgiev; Z Lalchev
Journal:  Eur Biophys J       Date:  2010-03-04       Impact factor: 1.733

4.  Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.

Authors:  D Beauchamp; M Pellerin; P Gourde; M Pettigrew; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

5.  Ceftriaxone protects against tobramycin nephrotoxicity.

Authors:  D Beauchamp; G Thériault; L Grenier; P Gourde; S Perron; Y Bergeron; L Fontaine; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin.

Authors:  M Couture; M Simard; P Gourde; C Lessard; K Gurnani; L Lin; D Carrier; M G Bergeron; D Beauchamp
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  Temporal variation in nephrotoxicity of low doses of isepamicin in rats.

Authors:  Y Yoshiyama; L Grenier; P Gourde; M Simard; L Lin; N J Morin; M G Bergeron; G Labrecque; D Beauchamp
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity.

Authors:  H D Humes; M Sastrasinh; J M Weinberg
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

Review 9.  Drug-induced ototoxicity. Pathogenesis and prevention.

Authors:  M Y Huang; J Schacht
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

10.  Aminoglycoside-induced increase of intracellular calcium in LLC-PK1 cells due to an artifact caused by trypsin and EDTA.

Authors:  S J Kohlhepp; K Hermsmeyer; R A Land; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.